Characteristics and Treatment Patterns of Patients With Chronic Obstructive Pulmonary Disease (COPD), Initiating Tio+Olo or Other Maintenance Therapies in the US and the UK: A Retrospective Claims Database Study

NCT04926233 · clinicaltrials.gov ↗

COMPLETED

Status

1371146

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: Tiotropium bromide + Olodaterol
DEVICE: Sp(t)iolto® Respimat®

Sponsor

Boehringer Ingelheim